{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:57:25Z","timestamp":1780365445459,"version":"3.54.1"},"publisher-location":"New York, NY","reference-count":39,"publisher":"Springer US","isbn-type":[{"value":"9781071610008","type":"print"},{"value":"9781071610015","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-1-0716-1001-5_20","type":"book-chapter","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T16:09:38Z","timestamp":1606147778000},"page":"295-335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma"],"prefix":"10.1007","author":[{"given":"Laura","family":"Hesse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjen H.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn C.","family":"Nawijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"key":"20_CR1","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/ni.1892","volume":"11","author":"HY Kim","year":"2010","unstructured":"Kim HY, DeKruyff RH, Umetsu DT (2010) The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat Immunol 11:577\u2013584. https:\/\/doi.org\/10.1038\/ni.1892","journal-title":"Nat Immunol"},{"key":"20_CR2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/sj.tpj.6500387","volume":"6","author":"ST Weiss","year":"2006","unstructured":"Weiss ST, Litonjua AA, Lange C, Lazarus R, Liggett SB, Bleecker ER, Tantisira KG (2006) Overview of the pharmacogenetics of asthma treatment. Pharmacogenomics J 6:311\u2013326. https:\/\/doi.org\/10.1038\/sj.tpj.6500387","journal-title":"Pharmacogenomics J"},{"key":"20_CR3","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1111\/cea.12963","volume":"47","author":"H Backman","year":"2017","unstructured":"Backman H, R\u00e4is\u00e4nen P, Hedman L, Stridsman C, Andersson M, Lindberg A, Lundb\u00e4ck B, R\u00f6nmark E (2017) Increased prevalence of allergic asthma from 1996 to 2006 and further to 2016-results from three population surveys. Clin Exp Allergy 47:1426\u20131435. https:\/\/doi.org\/10.1111\/cea.12963","journal-title":"Clin Exp Allergy"},{"key":"20_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ni.3049","volume":"16","author":"BN Lambrecht","year":"2014","unstructured":"Lambrecht BN, Hammad H (2014) The immunology of asthma. Nat Immunol 16:45\u201356. https:\/\/doi.org\/10.1038\/ni.3049","journal-title":"Nat Immunol"},{"key":"20_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nri2262","volume":"8","author":"ST Holgate","year":"2008","unstructured":"Holgate ST, Polosa R (2008) Treatment strategies for allergy and asthma. Nat Rev Immunol 8:218\u2013230. https:\/\/doi.org\/10.1038\/nri2262","journal-title":"Nat Rev Immunol"},{"key":"20_CR6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMoa1207363","volume":"354","author":"A Matte-martyn","year":"2011","unstructured":"Matte-martyn A, Sc B, Diaz-granados N, Sc B, Al-saidi F, Cooper AB, Guest CB, Mazer CD, Mehta S, Stewart TE, Barr A, Ph D, Cook D, Slutsky AS, Critical C, Trials C (2011) Long-term inhaled corticosteroids in preschool children at high risk for asthma. New Engl J Med 354:683\u2013693. https:\/\/doi.org\/10.1056\/NEJMoa1207363","journal-title":"New Engl J Med"},{"issue":"21","key":"20_CR7","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1056\/NEJMoa1104647","volume":"365","author":"TW Guilbert","year":"2011","unstructured":"Guilbert TW, Martinez FD, Lemanske RF, Strunk RC, Covar R, Szefler SJ, Boehmer S, Jackson DJ, Sorkness CA, Pharm D, Gern JE, Kelly HW, Pharm D, Friedman NJ, Mellon MH, Schatz M, Morgan WJ, Chinchilli VM, Ph D, Raissy HH, Pharm D, Bade E, Malka-rais J, Beigelman A, Taussig LM (2011) Daily or intermittent budesonide in preschool children with recurrent wheezing. N Engl J Med 365(21):1990\u20132001. https:\/\/doi.org\/10.1056\/NEJMoa1104647","journal-title":"N Engl J Med"},{"key":"20_CR8","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1053\/rmed.2000.0820","volume":"94","author":"RJ Hancox","year":"2000","unstructured":"Hancox RJ, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Taylor DR (2000) Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment. Respir Med 94:767\u2013771. https:\/\/doi.org\/10.1053\/rmed.2000.0820","journal-title":"Respir Med"},{"key":"20_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.prrv.2012.11.002","volume":"14","author":"RP Yim","year":"2013","unstructured":"Yim RP, Koumbourlis AC (2013) Tolerance & resistance to \u03b22-agonist bronchodilators. Paediatr Respir Rev 14:195\u2013198. https:\/\/doi.org\/10.1016\/j.prrv.2012.11.002","journal-title":"Paediatr Respir Rev"},{"key":"20_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s40521-014-0013-1","volume":"1","author":"M Jutel","year":"2014","unstructured":"Jutel M (2014) Allergen-specific immunotherapy in asthma. Curr Treat Options Allergy 1:213\u2013219. https:\/\/doi.org\/10.1007\/s40521-014-0013-1","journal-title":"Curr Treat Options Allergy"},{"key":"20_CR11","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/j.1398-9995.2007.01451.x","volume":"62","author":"L Jacobsen","year":"2007","unstructured":"Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, H\u00f8st A, Koivikko A, Norberg LA, Valovirta E, Wahn U, M\u00f6ller C (2007) Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 62:943\u2013948. https:\/\/doi.org\/10.1111\/j.1398-9995.2007.01451.x","journal-title":"Allergy"},{"key":"20_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3109\/02770903.2013.853082","volume":"51","author":"G Passalacqua","year":"2014","unstructured":"Passalacqua G (2014) Specific immunotherapy in asthma: a comprehensive review. J Asthma 51:29\u201333. https:\/\/doi.org\/10.3109\/02770903.2013.853082","journal-title":"J Asthma"},{"key":"20_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jaip.2014.01.004","volume":"2","author":"TG Epstein","year":"2014","unstructured":"Epstein TG, Liss GM, Murphy-Berendts K, Bernstein DI (2014) AAAAI\/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactions. J Allergy Clin Immunol Pract 2:161\u2013167.e3. https:\/\/doi.org\/10.1016\/j.jaip.2014.01.004","journal-title":"J Allergy Clin Immunol Pract"},{"key":"20_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/2045-7022-2-8","volume":"2","author":"L Jacobsen","year":"2012","unstructured":"Jacobsen L, Wahn U, Bilo MB (2012) Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy. Clin Transl Allergy 2:8. https:\/\/doi.org\/10.1186\/2045-7022-2-8","journal-title":"Clin Transl Allergy"},{"key":"20_CR15","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.jaci.2011.12.973","volume":"129","author":"SR Durham","year":"2012","unstructured":"Durham SR, Emminger W, Kapp A, de Monchy JGR, Rak S, Scadding GK, Wurtzen PA, Andersen JS, Tholstrup B, Riis B, Dahl R (2012) SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol 129:717\u2013725.e5. https:\/\/doi.org\/10.1016\/j.jaci.2011.12.973","journal-title":"J Allergy Clin Immunol"},{"key":"20_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jaci.2011.06.022","volume":"128","author":"A Didier","year":"2011","unstructured":"Didier A, Worm M, Horak F, Sussman G, de Beaumont O, Le Gall M, Melac M, Malling H-J (2011) Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol 128:559\u2013566. https:\/\/doi.org\/10.1016\/j.jaci.2011.06.022","journal-title":"J Allergy Clin Immunol"},{"key":"20_CR17","doi-asserted-by":"publisher","first-page":"7207","DOI":"10.4049\/jimmunol.165.12.7207","volume":"165","author":"EM Janssen","year":"2000","unstructured":"Janssen EM, van Oosterhout AJ, Nijkamp FP, van Eden W, Wauben MH (2000) The efficacy of immunotherapy in an experimental murine model of allergic asthma is related to the strength and site of T cell activation during immunotherapy. J Immunol 165:7207\u20137214. https:\/\/doi.org\/10.4049\/jimmunol.165.12.7207","journal-title":"J Immunol"},{"issue":"1","key":"20_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1165\/ajrcmb.21.1.3519","volume":"21","author":"EM Janssen","year":"1999","unstructured":"Janssen EM, Wauben MH, Jonker EH, Hofman G, Van Eden W, Nijkamp FP, Van Oosterhout AJ (1999) Opposite effects of immunotherapy with ovalbumin and the immunodominant T-cell epitope on airway eosinophilia and hyperresponsiveness in a murine model of allergic asthma. Am J Respir Cell Mol Biol 21(1):21\u201329. https:\/\/doi.org\/10.1165\/ajrcmb.21.1.3519","journal-title":"Am J Respir Cell Mol Biol"},{"key":"20_CR19","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.4049\/jimmunol.0903909","volume":"185","author":"S Shirinbak","year":"2010","unstructured":"Shirinbak S, Taher YA, Maazi H, Gras R, van Esch BCAM, Henricks PAJ, Samsom JN, Verbeek JS, Lambrecht BN, van Oosterhout AJM, Nawijn MC (2010) Suppression of Th2-driven airway inflammation by allergen immunotherapy is independent of B cell and Ig responses in mice. J Immunol 185:3857\u20133865. https:\/\/doi.org\/10.4049\/jimmunol.0903909","journal-title":"J Immunol"},{"key":"20_CR20","doi-asserted-by":"publisher","first-page":"5211","DOI":"10.4049\/jimmunol.180.8.5211","volume":"180","author":"YA Taher","year":"2008","unstructured":"Taher YA, van Esch BCAM, Hofman GA, Henricks PAJ, van Oosterhout AJM (2008) 1,25-dihydroxyvitamin d3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-\u03b2. J Immunol 180:5211\u20135221. https:\/\/doi.org\/10.4049\/jimmunol.180.8.5211","journal-title":"J Immunol"},{"key":"20_CR21","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1111\/j.1365-2222.2012.04064.x","volume":"42","author":"H Maazi","year":"2012","unstructured":"Maazi H, Shirinbak S, Willart M, Hammad HM, Cabanski M, Boon L, Ganesh V, Baru AM, Hansen G, Lambrecht BN, Sparwasser T, Nawijn MC, van Oosterhout AJM (2012) Contribution of regulatory T cells to alleviation of experimental allergic asthma after specific immunotherapy. Clin Exp Allergy 42:1519\u20131528. https:\/\/doi.org\/10.1111\/j.1365-2222.2012.04064.x","journal-title":"Clin Exp Allergy"},{"key":"20_CR22","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1183\/09031936.05.00089304","volume":"26","author":"JLM Vissers","year":"2005","unstructured":"Vissers JLM, van Esch BCAM, Hofman GA, van Oosterhout AJM (2005) Macrophages induce an allergen-specific and long-term suppression in a mouse asthma model. Eur Respir J 26:1040\u20131046. https:\/\/doi.org\/10.1183\/09031936.05.00089304","journal-title":"Eur Respir J"},{"key":"20_CR23","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/nri1246","volume":"3","author":"ML Kapsenberg","year":"2003","unstructured":"Kapsenberg ML (2003) Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 3:984\u2013993. https:\/\/doi.org\/10.1038\/nri1246","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"20_CR24","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1084\/jem.192.9.1213","volume":"192","author":"H Jonuleit","year":"2000","unstructured":"Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH (2000) Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192(9):1213\u20131222. https:\/\/doi.org\/10.1084\/jem.192.9.1213","journal-title":"J Exp Med"},{"issue":"8","key":"20_CR25","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/90604","volume":"2","author":"HL Weiner","year":"2001","unstructured":"Weiner HL (2001) The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells. Nat Immunol 2(8):671\u2013672. https:\/\/doi.org\/10.1038\/90604","journal-title":"Nat Immunol"},{"key":"20_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/cei.12041","volume":"172","author":"H Maazi","year":"2013","unstructured":"Maazi H, Shirinbak S, den Boef LE, Fallarino F, Volpi C, Nawijn MC, van Oosterhout AJM (2013) Cytotoxic T lymphocyte antigen 4-immunoglobulin G is a potent adjuvant for experimental allergen immunotherapy. Clin Exp Immunol 172:113\u2013120. https:\/\/doi.org\/10.1111\/cei.12041","journal-title":"Clin Exp Immunol"},{"key":"20_CR27","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.4049\/jimmunol.0900340","volume":"184","author":"AM Tan","year":"2010","unstructured":"Tan AM, Chen H-C, Pochard P, Eisenbarth SC, Herrick CA, Bottomly HK (2010) TLR4 signaling in stromal cells is critical for the initiation of allergic Th2 responses to inhaled antigen. J Immunol 184:3535\u20133544. https:\/\/doi.org\/10.4049\/jimmunol.0900340","journal-title":"J Immunol"},{"key":"20_CR28","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/cea.13169","volume":"48","author":"L Hesse","year":"2018","unstructured":"Hesse L, Brouwer U, Petersen AH, Gras R, Bosman L, Brimnes J, Oude Elberink JNG, van Oosterhout AJM, Nawijn MC (2018) Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma. Clin Exp Allergy 48:1035\u20131049. https:\/\/doi.org\/10.1111\/cea.13169","journal-title":"Clin Exp Allergy"},{"key":"20_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/all.13382","volume":"73","author":"L Hesse","year":"2018","unstructured":"Hesse L, van Ieperen N, Habraken C, Petersen AH, Korn S, Smilda T, Goedewaagen B, Ruiters MH, van der Graaf AC, Nawijn MC (2018) Subcutaneous immunotherapy with purified Der p1 and 2 suppresses type 2 immunity in a murine asthma model. Allergy 73:1\u201313. https:\/\/doi.org\/10.1111\/all.13382","journal-title":"Allergy"},{"issue":"12","key":"20_CR30","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1111\/all.13918","volume":"74","author":"L Hesse","year":"2019","unstructured":"Hesse L, Feenstra R, Ambrosini M, de Jager WA, Petersen A, Vietor H, Unger WWJ, van Kooyk Y, Nawijn MC (2019) Subcutaneous immunotherapy using modified Phl p5a-derived peptides efficiently alleviates allergic asthma in mice. Allergy 74(12):2495\u20132498. https:\/\/doi.org\/10.1111\/all.13918","journal-title":"Allergy"},{"key":"20_CR31","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.1365-2222.2006.02624.x","volume":"37","author":"J Brimnes","year":"2007","unstructured":"Brimnes J, Kildsgaard J, Jacobi H, Lund K (2007) Sublingual immunotherapy reduces allergic symptoms in a mouse model of rhinitis. Clin Exp Allergy 37:488\u2013497. https:\/\/doi.org\/10.1111\/j.1365-2222.2006.02624.x","journal-title":"Clin Exp Allergy"},{"issue":"7","key":"20_CR32","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/all.13135","volume":"72","author":"HJ Hoffmann","year":"2017","unstructured":"Hoffmann HJ, Valovirta E, Pfaar O, Moingeon P, Schmid JM, Skaarup SH, Cardell LO, Simonsen K, Larch\u00e9 M, Durham SR, S\u00f8rensen P (2017) Novel approaches and perspectives in allergen immunotherapy. Allergy 72(7):1022\u20131034. https:\/\/doi.org\/10.1111\/all.13135","journal-title":"Allergy"},{"issue":"2","key":"20_CR33","doi-asserted-by":"publisher","first-page":"E373","DOI":"10.9778\/cmajo.20160066","volume":"5","author":"J Elliott","year":"2017","unstructured":"Elliott J, Kelly SE, Johnston A, Skidmore B, Gomes T, Wells GA (2017) Allergen immunotherapy for the treatment of allergic rhinitis and\/or asthma: an umbrella review. CMAJ Open 5(2):E373\u2013E385. https:\/\/doi.org\/10.9778\/cmajo.20160066","journal-title":"CMAJ Open"},{"issue":"4","key":"20_CR34","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1172\/JCI45232","volume":"121","author":"F J\u00f6nsson","year":"2011","unstructured":"J\u00f6nsson F, Mancardi DA, Kita Y, Karasuyama H, Iannascoli B, Van Rooijen N, Shimizu T, Da\u00ebron M, Bruhns P (2011) Mouse and human neutrophils induce anaphylaxis. J Clin Invest 121(4):1484\u20131496. https:\/\/doi.org\/10.1172\/JCI45232","journal-title":"J Clin Invest"},{"key":"20_CR35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000478983","volume":"173","author":"G Marco-Mart\u00edn","year":"2017","unstructured":"Marco-Mart\u00edn G, La Rotta HA, V\u00e1zquez De La Torre M, Higaki Y, Zubeldia JM, Baeza ML (2017) Differences in the anaphylactic response between C3H\/HeOuJ and BALB\/c mice. Int Arch Allergy Immunol 173:204\u2013212. https:\/\/doi.org\/10.1159\/000478983","journal-title":"Int Arch Allergy Immunol"},{"key":"20_CR36","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.4049\/jimmunol.179.10.6696","volume":"179","author":"J Sun","year":"2007","unstructured":"Sun J, Arias K, Alvarez D, Fattouh R, Walker T, Goncharova S, Kim B, Waserman S, Reed J, Coyle AJ, Jordana M (2007) Impact of CD40 ligand, B cells, and mast cells in peanut-induced anaphylactic responses. J Immunol 179:6696\u20136703. https:\/\/doi.org\/10.4049\/jimmunol.179.10.6696","journal-title":"J Immunol"},{"key":"20_CR37","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jaci.2007.07.033","volume":"120","author":"FD Finkelman","year":"2007","unstructured":"Finkelman FD (2007) Anaphylaxis: lessons from mouse models. J Allergy Clin Immunol 120:506\u2013515. https:\/\/doi.org\/10.1016\/j.jaci.2007.07.033","journal-title":"J Allergy Clin Immunol"},{"key":"20_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3109\/01902148.2014.971921","volume":"41","author":"A Robichaud","year":"2015","unstructured":"Robichaud A, Fereydoonzad L, Urovitch IB, Brunet J-D (2015) Comparative study of three flexiVent system configurations using mechanical test loads. Exp Lung Res 41:84\u201392. https:\/\/doi.org\/10.3109\/01902148.2014.971921","journal-title":"Exp Lung Res"},{"issue":"8","key":"20_CR39","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1023\/b:ejep.0000036572.00663.f2","volume":"19","author":"JW Twisk","year":"2004","unstructured":"Twisk JW (2004) Longitudinal data analysis. A comparison between generalized estimating equations and random coefficient analysis. Eur J Epidemiol 19(8):769\u2013776. https:\/\/doi.org\/10.1023\/b:ejep.0000036572.00663.f2","journal-title":"Eur J Epidemiol"}],"container-title":["Methods in Molecular Biology","Animal Models of Allergic Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1001-5_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T17:45:22Z","timestamp":1606153522000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-0716-1001-5_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"ISBN":["9781071610008","9781071610015"],"references-count":39,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1001-5_20","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]},"assertion":[{"value":"24 November 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}